title: Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
abstract: OBJECTIVE
  To examine the acceptability and feasibility of medical abortion in Nigeria.
  
  
  METHODS
  In total, 250 women who were eligible for legal pregnancy termination with a gestational age of up to 63 days since last menstrual period were enrolled in Benin City and Zaria between May 2005 and October 2006. Participants received 200 mg of oral mifepristone in the clinic and then took 400 μg of oral misoprostol 2 days later-choosing to either return to the clinic or take it at home. Women returned 2 weeks later for an assessment of abortion status.
  
  
  RESULTS
  The vast majority (96.3%) of women had successful complete abortions. Ultrasound was used to determine outcome in less than one-third (28.9%) of participants. Most women (83.2%) took the misoprostol at home. Almost all (96.2%) participants were satisfied or very satisfied with the abortion method.
  
  
  CONCLUSIONS
  The introduction of medical abortion with mifepristone and misoprostol could greatly expand current method options and improve the quality of reproductive health care in Nigeria and other settings in which access to legal abortion services is limited.
authors: Department of Obstetrics and Gynaecology, University of Benin, Benin City, Nigeria; Women's Health and Research Centre, Benin City, Nigeria.
authors: Friday
authors: F
authors: Okonofua
authors: Department of Obstetrics and Gynecology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.
authors: Oladapo
authors: O
authors: Shittu
authors: Gynuity Health Projects, New York, USA. Electronic address: tshochet@gynuity.org.
authors: Tara
authors: T
authors: Shochet
authors: Gynuity Health Projects, New York, USA.
authors: Ayisha
authors: A
authors: Diop
authors: Gynuity Health Projects, New York, USA.
authors: Beverly
authors: B
authors: Winikoff
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000379:methods*; D000284:Administration, Oral; D000328:Adult; D000553:Ambulatory Care / Q000379:methods / Q000592:standards; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D016595:Misoprostol / Q000008:administration & dosage*; D009549:Nigeria; D017060:Patient Satisfaction; D011247:Pregnancy; D011787:Quality of Health Care; D055815:Young Adult
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone
keywords: Medical abortion; Mifepristone; Misoprostol; Nigeria